| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910857794203321 |
|
|
Autore |
Ahmed Shakeel |
|
|
Titolo |
Biobased Nanomaterials : Applications in Biomedicine, Food Industry, Agriculture, and Environmental Sustainability |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Singapore : , : Springer Singapore Pte. Limited, , 2024 |
|
©2024 |
|
|
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Edizione |
[1st ed.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (535 pages) |
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Nota di contenuto |
|
Intro -- Preface -- Description -- Key Highlights -- Contents -- Editor and Contributors -- About the Editor -- Contributors -- Part I: Introduction, Synthesis and Characterization -- 1: Introduction to Biobased Nanomaterials -- 1.1 Introduction -- 1.2 Bionanomaterials -- 1.3 Classification and Synthesis Mechanisms of Bionanomaterials -- 1.3.1 Direct Bionanoparticle Synthesis -- 1.3.2 Indirect Bionanoparticle Synthesis -- 1.4 Approaches for Nanomaterial Synthesis -- 1.4.1 The Top-Down Approach -- 1.4.2 The Bottom-Up Approach -- 1.5 Application Areas of Bionanotechnology -- 1.6 Conclusions -- References -- 2: Types of Biobased Nanomaterials -- 2.1 Introduction -- 2.2 Sources of Biobased Nanomaterials -- 2.3 Biobased Nanomaterials -- 2.4 Types of Biobased Nanomaterials -- 2.4.1 Organic Nanomaterials -- 2.4.1.1 Micelles -- The Structure of Micelles -- Formation of Micelles -- Micelles: Their Uses and Functions -- 2.4.1.2 Dendrimers -- Dendrimer Structure and Chemistry -- Synthesis and Types of Dendrimers -- Dendrimer Characteristics -- Applications of Dendrimers -- 2.4.1.3 Polymersomes -- 2.4.1.4 Hydrogels -- 2.4.1.5 Nanoconjugates -- 2.4.1.6 Cyclodextrins (CDs) -- 2.4.1.7 Liposomes -- 2.4.2 Inorganic Nanomaterials -- 2.4.2.1 Metal-Based Inorganic Nanomaterials -- 2.4.2.2 Metal Oxide-Based Inorganic Nanomaterials -- 2.4.2.3 Ceramic Nanomaterials (CNPs) -- 2.4.3 Compound-Based Nanomaterials -- 2.4.4 Carbon-Based Nanomaterials -- 2.4.4.1 |
|
|
|
|
|
|
|
|
|
Graphene -- 2.4.4.2 Fullerenes -- Properties of Fullerenes -- Varieties of Fullerenes -- 2.4.4.3 Single-Walled Carbon Nanotubes -- 2.4.4.4 Multiwalled Carbon Nanotubes -- 2.5 Conclusions -- References -- 3: Synthesis of Bionanomaterials Using Different Extracts -- 3.1 Introduction -- 3.1.1 The Top-Down Approach -- 3.1.2 The Bottom-Up Approach -- 3.2 Green Synthesis of Nanomaterials. |
3.2.1 Plant Extracts -- 3.2.2 Microorganisms -- 3.2.3 Bacteria -- 3.2.4 Fungi -- 3.2.5 Biomolecules -- 3.2.6 Algae -- 3.3 Conclusions -- References -- 4: Physiochemical Characterization Technique of Bionanomaterials -- 4.1 Introduction -- 4.2 Summary of the Physical and Chemical Traits of NMs -- 4.2.1 Size -- 4.2.2 Surface-Specific Features -- 4.2.3 Configuration -- 4.2.4 Composition and Purity -- 4.2.5 The Degree of Stability -- 4.2.6 Relationship Between Nanomaterials and Their Biological Environments -- 4.3 Microscopy-Based Technique -- 4.3.1 Near-Field Scanning Optical Microscopy (NSOM) -- 4.3.2 Scanning Electron Microscopy (SEM) -- 4.3.3 Transmission Electron Microscopy (TEM) -- 4.3.4 Scanning Tunnelling Microscopy (STM) -- 4.3.5 Atomic Force Microscopy (AFM) -- 4.4 Radiation-Based Technique -- 4.4.1 Dynamic Light Scattering (DLS) -- 4.4.2 X-Ray Diffraction (XRD) -- 4.4.3 Small-Angle X-Ray Scattering (SAXS) -- 4.4.4 Raman Scattering (RS) -- 4.4.5 Circular Dichroism (CD) -- 4.5 Spectroscopy-Based Technique -- 4.5.1 Infrared (IR) Spectroscopy -- 4.5.2 Nuclear Magnetic Resonance (NMR) -- 4.5.3 Mass Spectrometry (MS) -- 4.5.4 Fluorescence Correlation Spectroscopy (FCS) -- 4.5.5 Fluorescence Spectroscopy (FS) -- 4.6 Chromatography-Based Technique -- 4.6.1 High-Performance Liquid Chromatography (HPLC) -- 4.6.2 Hydrodynamic Chromatography (HDC) -- 4.6.3 Field-Flow Fractionation (FFF) -- 4.7 Other Techniques -- 4.7.1 Zeta Potential -- 4.7.2 Nanomaterial Tracking Analysis (NTA) -- 4.7.3 The Brunauer-Emmett-Teller (BET) Method -- 4.7.4 The Barrett-Joyner-Halenda (BJH) Method -- 4.7.5 Analytical Ultracentrifugation (AUC) -- 4.7.6 High-Angle Annular Dark-Field (HAADF) Imaging -- 4.7.7 Polarized Optical Microscopy (POM) -- 4.8 Conclusions -- References -- Part II: Biobased Nanomaterials in Biomedical Applications. |
5: Revolutionizing Regeneration: Bio-Based Nanomaterials in Tissue Engineering -- 5.1 Introduction -- 5.2 Properties or Requirements of Bio-Based Nanoscaffold for Tissue Engineering -- 5.2.1 Microarchitecture -- 5.2.2 Biocompatibility -- 5.2.3 Biodegradability -- 5.2.4 Mechanical Properties -- 5.2.5 Bioactivity -- 5.3 Biomaterials Used for Developing the Nanoscaffold -- 5.3.1 Cellulose -- 5.3.2 Alginate -- 5.3.3 Chitin and Chitosan -- 5.3.4 Hyaluronic Acid -- 5.3.5 Starch -- 5.3.6 Collagen -- 5.3.7 Keratin -- 5.3.8 Elastin -- 5.3.9 Fibrin -- 5.3.10 Gelatin -- 5.4 Bio-Based Nanomaterials Fabrication Techniques -- 5.4.1 Solvent Casting and Particle Leaching -- 5.4.2 Electrospinning -- 5.4.3 Thermal-Induced Phase Separation Method -- 5.4.4 Freeze Drying -- 5.4.5 Gas Foaming -- 5.4.6 Selective Laser Sintering -- 5.4.7 Solvent-Based Extrusion 3D Printing Method -- 5.4.8 Stereolithography -- 5.4.9 Bioprinting Method -- 5.4.10 Aerosol Jet Printing -- 5.5 Applications of Bio-Based Nanomaterials for Tissue Engineering -- 5.5.1 Bone Tissue Engineering -- 5.5.2 Cardiac Tissue Engineering -- 5.5.3 Skeletal Muscle Tissue Engineering -- 5.5.4 Skin Tissue Engineering -- 5.5.5 Nervous Tissue Engineering -- 5.6 Conclusions -- References -- 6: Biobased Nanomaterials in Biomedical Applications -- 6.1 Introduction -- 6.1.1 Importance of Nanotechnology in Biomedical Application -- 6.2 Synthesis and Characterization of Biobased Nanomaterials -- 6.2.1 Green Synthesis of Biobased Nanoparticles -- |
|
|
|
|
|
|
|
6.2.2 Characterization Techniques for Biobased Nanomaterials -- 6.2.2.1 Nanoparticle Formation Analysis -- 6.2.2.2 Nanoparticle Extraction Analysis -- 6.2.2.3 Morphology and Particle Size Determination -- 6.2.2.4 Surface Charge Analysis -- 6.2.2.5 XPS -- 6.2.2.6 FT-IR Spectroscopy -- 6.2.2.7 Zeta Sizer Nanomachine -- 6.2.2.8 TGA. |
6.2.2.9 Surface Hydrophobicity Assessment -- 6.2.2.10 Analysis of Nanoparticle Magnetic Properties -- 6.2.3 Biocompatibility and Safety Considerations -- 6.3 Biobased Nanomaterials for Drug Delivery -- 6.3.1 Nanocarriers for Drug Encapsulation -- 6.3.2 Targeted Drug Delivery Systems -- 6.3.3 Controlled Release Strategies -- 6.3.4 Overcoming Biological Barriers with Biobased Nanomaterials -- 6.4 Biobased Nanomaterials in Diagnostics and Imaging -- 6.4.1 Nanoprobes for Imaging and Sensing -- 6.4.2 Contrast Agents for Biomedical Imaging -- 6.4.3 Biosensors and Point-of-Care Devices -- 6.5 Biobased Nanomaterials for Tissue Engineering and Regenerative Medicine -- 6.5.1 Key Elements of Tissue Engineering -- 6.5.2 Nanomaterials for Scaffold Design -- 6.5.2.1 Microarchitecture -- 6.5.2.2 Biodegradability -- 6.5.2.3 Biocompatibility -- 6.5.2.4 Bioactivity -- 6.5.3 Cellular Interaction and Biocompatibility -- 6.6 Biobased Nanomaterials in Cancer Therapy -- 6.6.1 Nanoparticles for Cancer Diagnosis -- 6.6.2 Targeted Therapies Using Biobased Nanomaterials -- 6.6.3 Nanoparticle-Mediated Photothermal and Photodynamic Therapy -- 6.7 Biobased Nanomaterials for Wound Healing and Infection Control -- 6.7.1 Nanofibers and Dressings -- 6.7.1.1 Semipermeable Film Dressings -- 6.7.1.2 Semipermeable Foam Dressings -- 6.7.2 Antimicrobial Nanoparticles -- 6.7.3 Bioactive Coatings and Films -- 6.8 Biobased Nanomaterials in Dental Applications -- 6.8.1 Nanocomposites for Dental Restorations -- 6.8.2 Nanoparticles for Oral Drug Delivery -- 6.8.3 Nanomaterials for Periodontal Treatment -- 6.9 Biobased Nanomaterials for Neurological Disorders -- 6.9.1 Nanotherapeutics for Brain Delivery -- 6.9.2 Nanosensors and Neural Interfaces -- 6.9.3 Neuro-regeneration with Biobased Nanomaterials. |
6.10 Regulatory and Ethical Considerations in Biobased Nanomaterials -- 6.10.1 Safety and Toxicity Assessment -- 6.10.2 Environmental Impact -- 6.10.3 Ethical Issues in Nanomedicine -- 6.11 Future Perspectives and Challenge -- 6.11.1 Emerging Trends in Biobased Nanomaterials -- 6.11.2 Potential Clinical Translations -- 6.11.3 Addressing Key Challenges in Biomedical Applications -- 6.12 Conclusion -- References -- 7: Biobased Nanomaterials in Drug Delivery -- 7.1 Introduction -- 7.2 What Is Nanomaterial? -- 7.2.1 Usage Areas of Nanomaterials -- 7.2.1.1 Food Industry -- 7.2.1.2 Cancer Treatment -- 7.2.1.3 Tissue Engineering -- 7.3 What Is Biobased Nanomaterial? -- 7.4 Sources of Biobased Nanomaterials -- 7.4.1 Polysaccharides -- 7.4.2 Polymers Used in Controlled Drug Release Systems -- 7.4.3 Chitosan -- 7.5 Drug Delivery -- 7.6 Biobased Nanomaterials Used in Drug Delivery -- 7.6.1 Chitin -- 7.6.2 Chitosan (CS) -- 7.6.2.1 Chitosan-Clay Bionanocomposites Applications in Drug Delivery -- 7.6.2.2 Chitosan Bionanocomposites for Controlled Release Applications -- 7.6.3 Cellulose -- 7.6.4 Carbon-Based Nanomaterials -- 7.6.5 Starch -- 7.6.6 Plant Proteins -- 7.6.7 Phage in Drug Delivery -- 7.7 Drug Delivery and Cancer -- 7.8 Drug Delivery and Other Diseases -- 7.9 Conclusion -- References -- 8: Biobased Nanomaterials in Regenerative Medicines -- 8.1 Introduction -- 8.2 Scaffolds Bionanocomposites as Regenerative Medicines -- 8.3 Bioactive Glasses Bionanocomposites as Regenerative Medicines -- 8.4 Natural Polymers Bionanocomposites as Regenerative |
|
|
|
|
|
|
|
|
Medicines -- 8.5 Drawback of Natural Polymers Bionanocomposites as Regenerative Medicines -- 8.6 Composites Bionanocomposites as Regenerative Medicines -- 8.7 Chitin Bionanocomposites as Regenerative Medicines -- 8.8 Chitin Scaffolds Bionanocomposites as Regenerative Medicines. |
8.9 Bone Bionanocomposites as Regenerative Medicines. |
|
|
|
|
|
| |